Gene Editing (BK2569) Stock Forum and Discussion

Gene Editing Watchlist

Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.

1298.913
-7.525-0.58%

Close Dec 27 16:00 ET

1307.237High1288.468Low

Constituent Stocks: 10Top Rising: BLUE0.00%

101721316

6 hours ago

$Vertex Pharmaceuticals (VRTX.US)$ long term play

Kim10

Dec 24 23:20

$CRISPR Therapeutics (CRSP.US)$ I wonder if it's cathy that's selling all these premiums

Bull X Bear

Dec 23 15:19

Learning from Historic Events | 从历史事件中学习

The performance of U.S. markets at the year-end and the beginning of a new year, particularly during a presidential inauguration year, often depends on several historical and economic factors. Here’s an overview based on trends and historical precedence:
Year-End Market Trends (“Santa Claus Rally”)
1. Santa Claus Rally:
Historically, U.S. markets often experience a “Santa Claus Rally” during the last week of December through the first two trading days of ...

Record highs for S&P and Nasdaq: Is the "Santa Rally" on its way?

Wekang

Dec 23 09:01

the eps is increasing trend as well as net margin.. Im holding on to this..

Share Your Profit/Loss

BigAlMoney

Dec 20 16:48

Fabry deal still in the works

$Sangamo Therapeutics (SGMO.US)$
Should be interesting to see what we get in up front. It's been given Accelerated Approval by FDA so BLA will be filed next year sometime once we get final patient data. I'm guessing 100 to 200 million up front.